Local Institution

Paderborn 33098

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Lung Cancer, Non-Small Cell Lung Cancer, Stomach Cancer

Studies at this site

• An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Phase III Acute Coronary Syndrome — Stopped early